R Scott Huennekens's Insider Trades & SAST Disclosures
R Scott Huennekens's most recent trade in NeuroPace Inc was a trade of 15,507 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern R Scott Huennekens.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NeuroPace Inc | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 15,507 | 15,507 | - | - | Stock Option (Right to Buy) | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 79,200 | 79,200 | - | - | Stock Options (right to buy) | |
| Envista Holdings Corp | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 14,170 | 55,150 (0%) | 0% | 0 | Common Stock | |
| Acutus Medical Inc | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 25,480 | 25,480 | - | - | FORM 4 | |
| Acutus Medical Inc | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,920 | 21,840 | - | 0 | FORM 4 | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jun 2023 | 237,437 | 0 | - | - | Stock Options (right to buy) | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 237,437 | 237,437 | - | - | Stock Option (right to buy) | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 112,000 | 112,000 | - | - | Stock Options (right to buy) | |
| Envista Holdings Corp | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 7,625 | 40,980 (0%) | 0% | 0 | Common Stock | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2022 | 712,312 | 0 | - | - | Stock Option (right to buy) | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 712,312 | 712,312 | - | - | Stock Option (right to buy) | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 237,437 | 237,437 | - | - | Stock Option (right to buy) | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2022 | 237,437 | 0 | - | - | Stock Option (right to buy) | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 237,437 | 237,437 | - | - | Stock Option (right to buy) | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2022 | 237,437 | 0 | - | - | Stock Option (right to buy) | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 237,437 | 237,437 | - | - | Stock Option (right to buy) | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Oct 2022 | 237,437 | 0 | - | - | Stock Option (right to buy) | |
| Acutus Medical Inc | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 5,880 | 5,880 | - | - | Stock Options (Right to Buy) | |
| Acutus Medical Inc | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 2,520 | 10,920 | - | 0 | Common Stock | |
| Acutus Medical Inc | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 19,600 | 19,600 | - | - | Stock Options (Right to Buy) | |
| Acutus Medical Inc | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,400 | 8,400 | - | 0 | Common Stock | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 85,345 | 85,345 | - | - | Stock Options (right to buy) | |
| Envista Holdings Corp | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 5,930 | 33,355 (0%) | 0% | 0 | Common Stock | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2022 | 237,437 | 237,437 | - | - | Stock Option (right to buy) | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 712,312 | 712,312 | - | - | Stock Option (right to buy) | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 237,437 | 237,437 | - | - | Stock Option (right to buy) | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 237,437 | 237,437 | - | - | Stock Option (right to buy) | |
| Hyperfine Inc - Ordinary S... | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 19,586 | 19,586 | - | 0 | Class A Common Stock | |
| Envista Holdings Corp | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 5,455 | 27,425 (0%) | 0% | 0 | Common Stock | |
| Envista Holdings Corp | R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2020 | 11,170 | 11,170 | - | - | Restricted Stock Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges